Gallstones and biliary sludge are known triggers for acute pancreatitis, potentially creating an indirect pathway between these medications and pancreatic inflammation in some patients
These risks look quite different from those of diabetic patients who already face gastric motility disorders
This reduces long-term costs compared to clinic-dependent approaches, though it places more responsibility on the researcher for proper technique and consistency
While oral formulations are emerging, injectable solutions continue to lead due to their established clinical success in managing blood glucose levels, providing healthcare providers with reliable options for managing T2DM and obesity in patients requiring stable, consistent dosing
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials
However, further research is needed to understand their full potential and all details of their mechanism of action, which will enable to expand the therapeutic indications and to determine their optimal use in clinical practice